NA
ABMD

Navellier & Associates’s Abiomed Inc ABMD Stock Holding History

Navellier & Associates’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-1,131
Closed -$201K – 322
2019
Q3 		$201K Buy
1,131
+10
+0.9% +$2.16K 0.03% 256
2019
Q2 		$292K Sell
1,121
-26,042
-96% -$6.91M 0.05% 215
2019
Q1 		$7.76M Buy
27,163
+3,609
+15% +$1.2M 1.2% 21
2018
Q4 		$7.66M Buy
23,554
+1,150
+5% +$399K 1.3% 9
2018
Q3 		$10.1M Buy
22,404
+551
+3% +$217K 1.3% 13
2018
Q2 		$8.94M Buy
21,853
+11,000
+101% +$3.99M 1.24% 17
2018
Q1 		$3.16M Buy
10,853
+1,300
+14% +$329K 0.48% 55
2017
Q4 		$1.79M Buy
9,553
+5,305
+125% +$990K 0.33% 96
2017
Q3 		$716K Sell
4,248
-953
-18% -$144K 0.14% 115
2017
Q2 		$745K Sell
5,201
-559
-10% -$75.1K 0.11% 152
2017
Q1 		$721K Sell
5,760
-3,998
-41% -$463K 0.11% 161
2016
Q4 		$1.1M Buy
9,758
+1,717
+21% +$199K 0.18% 134
2016
Q3 		$1.03M Sell
8,041
-913
-10% -$109K 0.15% 127
2016
Q2 		$979K Sell
8,954
-88
-1% -$8.76K 0.15% 101
2016
Q1 		$857K Buy
9,042
+162
+2% +$13.7K 0.11% 92
2015
Q4 		$802K Sell
8,880
-4,523
-34% -$384K 0.09% 94
2015
Q3 		$1.24M Sell
13,403
-2,074
-13% -$183K 0.13% 76
2015
Q2 		$1.02M Buy
15,477
+1,209
+8% +$80.3K 0.09% 119
2015
Q1 		$1.02M Buy
+14,268
New +$774K 0.09% 110

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Navellier & Associates's ABMD Position: Q4 2019 in Review

Navellier & Associates sold out of Abiomed Inc (ABMD) in Q4 2019, closing a stake of 1,131 shares — an estimated $201K sold.

Navellier & Associates first reported a position in ABMD in Q1 2015 and held it in 19 quarters. The position peaked at $10.1M in Q3 2018. 465 funds tracked by Wall St. Rank hold ABMD as of Q4 2019.

  • Navellier & Associates reported no remaining Abiomed Inc position as of Q4 2019 after selling out during the quarter.
  • Navellier & Associates sold 1,131 Abiomed Inc shares in Q4 2019, an estimated $201K.
  • Navellier & Associates first reported a position in Abiomed Inc in Q1 2015 and held it in 19 quarters.
  • Navellier & Associates's Abiomed Inc position peaked at $10.1M in Q3 2018.
  • 465 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2019.

Based on Navellier & Associates's 13F filing for Q4 2019, filed 12 Feb 2020.